Negative Regulation of the Creatine Transporter SLC6A8 by SPAK and OSR1
Overview
Affiliations
Background/aims: Transport regulation involves several kinases including SPAK (SPS1-related proline/alanine-rich kinase) and OSR1 (oxidative stress-responsive kinase 1), which are under control of WNK (with-no-K[Lys]) kinases. The present study explored whether SPAK and/or OSR1 participate in the regulation of the creatine transporter CreaT (SLC6A8), which accomplishes Na+ coupled cellular uptake of creatine in several tissues including kidney, intestine, heart, skeletal muscle and brain.
Methods: cRNA encoding SLC6A8 was injected into Xenopus laevis oocytes with or without additional injection of cRNA encoding wild-type SPAK, constitutively active (T233E)SPAK, WNK insensitive (T233A)SPAK, catalytically inactive (D212A)SPAK, wild-type OSR1, constitutively active (T185E)OSR1, WNK insensitive (T185A)OSR1 and catalytically inactive (D164A)OSR1. Transporter activity was determined from creatine (1 mM) induced current utilizing dual electrode voltage clamp.
Results: Coexpression of wild-type SPAK and of (T233E)SPAK, but not of (T233A)SPAK or of (D212A)SPAK was followed by a significant decrease of creatine induced current in SLC6A8 expressing oocytes. Coexpression of SPAK significantly decreased maximal transport rate. Coexpression of wild-type OSR1, (T185E)OSR1 and (T185A)OSR1 but not of (D164A)OSR1 significantly negatively regulated SLC6A8 activity. OSR1 again decreased significantly maximal transport rate.
Conclusions: Both, SPAK and OSR1, are negative regulators of the creatine transporter SLC6A8.
Bonilla D, Moreno Y, Rawson E, Forero D, Stout J, Kerksick C Nutrients. 2021; 13(8).
PMID: 34444681 PMC: 8397972. DOI: 10.3390/nu13082521.
Bi Y, Li C, Zhang Y, Wang Y, Chen S, Yue Q Front Physiol. 2020; 11:638.
PMID: 32714200 PMC: 7343913. DOI: 10.3389/fphys.2020.00638.
Hall C, Lee J, Murphy E, Gerich M, Dran R, Glover L Gastroenterology. 2020; 159(3):984-998.e1.
PMID: 32433978 PMC: 7891846. DOI: 10.1053/j.gastro.2020.05.033.
Santos-Reboucas C, Boy R, Vianna E, Goncalves A, Piergiorge R, Abdala B Front Genet. 2020; 11:101.
PMID: 32194616 PMC: 7064548. DOI: 10.3389/fgene.2020.00101.
Raider K, Ma D, Harris J, Fuentes I, Rogers R, Wheatley J Neurochem Int. 2016; 97:172-80.
PMID: 27125544 PMC: 4900919. DOI: 10.1016/j.neuint.2016.04.008.